ABSTRACT
The COVID-19 pandemic was initiated by the rapid spread of a SARS-CoV-2 strain. Though mainly classified as a respiratory disease, SARS-CoV-2 infects multiple tissues throughout the human body, leading to a wide range of symptoms in patients. To better understand how SARS-CoV-2 affects the proteome from cells with different ontologies, this work generated an infectome atlas of 9 cell models, including cells from brain, blood, digestive system, and adipocyte tissue. Our data shows that SARS-CoV-2 infection mainly trigger dysregulations on proteins related to cellular structure and energy metabolism. Despite these pivotal processes, heterogeneity of infection was also observed, highlighting many proteins and pathways uniquely dysregulated in one cell type or ontological group. These data have been made searchable online via a tool that will permit future submissions of proteomic data ( https://reisdeoliveira.shinyapps.io/Infectome_App/ ) to enrich and expand this knowledgebase.
Subject(s)
COVID-19 , SARS-CoV-2 , Humans , Proteomics , PandemicsABSTRACT
MicroRNAs (miRNAs) are potent regulators of multiple biological processes. Previous studies have demonstrated that miR-146a-5p increases in normal mice during aging, while long-living Ames dwarf (df/df) mice maintain youthful levels of this miRNA. The aim of this study was to elucidate the involvement of miR-146a-5p in modulating cellular senescence and apoptosis in visceral adipose tissue of df/df mice and cultured pre-adipocytes. To test the effects of miR-146a-5p overexpression on visceral adipose tissue, wild-type, and df/df mice, were treated with miRNA-negative control-base and df/df were transfected with 4 or 8 µg/g of a miR-146a-5p mimetic, respectively. Effects of miR-146a-5p overexpression were also evaluated in 3T3-L1 cells cultured under high and normal glucose conditions. Treatment with miR-146a-5p mimetic increased cellular senescence and inflammation and decreased pro-apoptotic factors in visceral adipose tissue of df/df mice. The miR-146a-5p mimetic induced similar effects in 3T3-L1 cells cultivated at normal but not high glucose levels. Importantly, 3T3-L1 HG cells in high glucose conditions showed significantly higher expression of miR-146a-5p than 3T3-L1 grown in normal glucose conditions. These results indicate that miR-146a-5p can be a marker for cellular senescence. This miRNA represents one of the significant SASP factors that if not precisely regulated, can accentuate inflammatory responses and stimulate senescence in surrounding non-senescent cells. The role of miR-146a-5p is different in healthy versus stressed cells, suggesting potential effects of this miRNA depend on overall organismal health, aging, and metabolic state.
Subject(s)
Adipocytes/cytology , Cellular Senescence , Intra-Abdominal Fat , MicroRNAs , 3T3-L1 Cells , Animals , Apoptosis , Intra-Abdominal Fat/cytology , Longevity , Mice , Mice, Inbred Strains , MicroRNAs/geneticsABSTRACT
Visceral adiposity is a risk factor for severe COVID-19, and a link between adipose tissue infection and disease progression has been proposed. Here we demonstrate that SARS-CoV-2 infects human adipose tissue and undergoes productive infection in fat cells. However, susceptibility to infection and the cellular response depends on the anatomical origin of the cells and the viral lineage. Visceral fat cells express more ACE2 and are more susceptible to SARS-CoV-2 infection than their subcutaneous counterparts. SARS-CoV-2 infection leads to inhibition of lipolysis in subcutaneous fat cells, while in visceral fat cells, it results in higher expression of pro-inflammatory cytokines. Viral load and cellular response are attenuated when visceral fat cells are infected with the SARS-CoV-2 gamma variant. A similar degree of cell death occurs 4-days after SARS-CoV-2 infection, regardless of the cell origin or viral lineage. Hence, SARS-CoV-2 infects human fat cells, replicating and altering cell function and viability in a depot- and viral lineage-dependent fashion.
Subject(s)
COVID-19 , SARS-CoV-2 , Adipose Tissue , Angiotensin-Converting Enzyme 2 , Cytokines , HumansABSTRACT
Head and Neck Squamous Cell Carcinoma (HNSCC) is the sixth most common cancer worldwide. These tumors originate from epithelial cells of the upper aerodigestive tract. HNSCC tumors in different regions can have significantly different molecular characteristics. While many microRNAs (miRNAs) have been found to be involved in the regulation of the carcinogenesis and pathogenesis of HNSCC, new HNSCC related miRNAs are still being discovered. The aim of this study was to explore potential miRNA biomarkers that can be used to diagnose HNSCC and prognose survival of HNSCC patients. For this purpose, we chose a panel of 12 miRNAs: miR-146a-5p, miR-449a, miR-126-5p, miR-34a-5p, miR-34b-5p, miR-34c-5p, miR-217-5p, miR-378c, miR-6510-3p, miR-96-5p, miR-149-5p, and miR-133a-5p. Expression of these miRNAs was measured in tumor tissue and neighboring healthy tissue collected from patients diagnosed with HNSCC (n = 79) in either the oral cavity, oropharynx, or larynx. We observed a pattern of differentially expressed miRNAs at each of these cancer locations. Our study showed that some of these miRNAs, separately or in combination, could serve as biomarkers distinguishing between healthy and tumor tissue, and their expression correlated with patients' overall survival.
ABSTRACT
Cellular senescence contributes to age-related disorders including physical dysfunction, disabilities, and mortality caused by tissue inflammation and damage. Senescent cells accumulate in multiple tissues with aging and at etiological sites of multiple chronic disorders. The senolytic drug combination, Dasatinib plus Quercetin (D+Q), is known to reduce senescent cell abundance in aged mice. However, the effects of long-term D+Q treatment on intestinal senescent cell and inflammatory burden and microbiome composition in aged mice remain unknown. Here, we examine the effect of D+Q on senescence (p16Ink4a and p21Cip1) and inflammation (Cxcl1, Il1ß, Il6, Mcp1, and Tnfα) markers in small (ileum) and large (caecum and colon) intestine in aged mice (n = 10) compared to age-matched placebo-treated mice (n = 10). Additionally, we examine microbial composition along the intestinal tract in these mice. D+Q-treated mice show significantly lower senescent cell (p16 and p21 expression) and inflammatory (Cxcl1, Il1ß, Il6, Mcp1, and Tnfα expression) burden in small and large intestine compared with control mice. Further, we find specific microbial signatures in ileal, cecal, colonic, and fecal regions that are distinctly modulated by D+Q, with modulation being most prominent in small intestine. Further analyses reveal specific correlation of senescence and inflammation markers with specific microbial signatures. Together, these data demonstrate that the senolytic treatment reduces intestinal senescence and inflammation while altering specific microbiota signatures and suggest that the optimized senolytic regimens might improve health via reducing intestinal senescence, inflammation, and microbial dysbiosis in older subjects.
Subject(s)
Dasatinib , Gastrointestinal Microbiome , Quercetin , Animals , Biomarkers , Cellular Senescence/drug effects , Dasatinib/pharmacology , Inflammation/drug therapy , Interleukin-6 , Intestines , Mice , Quercetin/pharmacology , Senotherapeutics , Tumor Necrosis Factor-alphaABSTRACT
The aim of this study was to evaluate the effect of growth hormone (GH) deficiency in primordial follicle reserve, DNA damage and macrophage infiltration in the ovaries of young mice. Ovaries from six-month-old GH-deficient Ames Dwarf (df/df) and Normal (N/df) mice were used. The number of primordial follicles was higher in df/df mice (p = 0.0026). Also, df/df mice had a lower number of primary (p = 0.023), secondary (p = 0.0052) and tertiary (p = 0.019) follicles. These findings indicate a slower rate of primordial follicle activation in df/df mice. Female df/df mice had decreased γH2AX foci intensity in oocytes of primordial (p = 0.015) and primary (p = 0.0004) follicles compared to N/df mice. Also, df/df mice had reduced γH2AX intensity in granulosa cells of primordial (p = 0.0002) and primary (p < 0.0001) follicles. Overall, this indicate to us that df/df mice accumulate less DNA damage in the ovarian reserve compared to N/df mice. Additionally, macrophage infiltration was also reduced in ovaries of df/df mice compared to N/df mice (p = 0.033). Interestingly, df/df mice had a reduced number of granulosa cells around primordial (p = 0.0024) and primary (p = 0.007) follicles compared to N/df mice. Also, df/df mice had a small diameter of primordial follicle nuclei (p = 0.0093), secondary follicle oocyte (p = 0.046) and tertiary follicle (p = 0.012). This points to the role of granulosa cell proliferation and oocyte growth for primordial follicle activation. The current study points to the role of the GH/IGF-I axis in extending lifespan of reproductive health, along with maintenance of oocyte DNA integrity and reduced ovarian inflammation.
Subject(s)
DNA Damage , Macrophages/physiology , Ovarian Follicle/physiology , Ovarian Reserve/genetics , Animals , Female , Granulosa Cells/physiology , Growth Hormone/deficiency , Longevity , Mice , Oocytes/physiology , Ovary/physiologyABSTRACT
Introdução: A obesidade representa hoje um importante problema de saúde pública e cresce o número de pacientes obesos atendidos nos ambulatórios de nutrição. Objetivo: Avaliar o perfil e a variação de peso corporal dos pacientes obesos atendidos em ambulatório de nutrição do Sul do Brasil, entre janeiro de 2007 e junho de 2012. Métodos: Estudo retrospectivo com dados secundários, obtidos dos prontuários de pacientes obesos de ambos os sexos, com idade maior ou igual a 18 anos, que freqüentaram pelo menos duas consultas neste serviço de saúde. O desfecho do estudo foi a porcentagem de variação de peso entre a primeira e a última consulta no período. As variáveis avaliadas foram: idade, diagnóstico, número de consultas, tempo de intervenção, uso de cigarros e consumo de bebida atuais, funcionamento intestinal, prática de atividade física e IMC na primeira e última consulta. Para as aná- lises estatísticas, foram utilizados os testes de qui-quadrado, Kruskal Wallis e Bonferroni (Stata® 11.1), sendo considerados significativos os valores de p<0,05. Resultados: Dos 451 pacientes obesos, a maioria (79,2%) era do sexo feminino e somente 2,8% freqüentou o ambulatório por mais de 24 meses. Mais da metade da amostra apresentou perda de até 5% do peso inicial e quanto maior o número de consultas e o tempo de intervenção, maior o percentual de perda de peso. Discussão: Assim como em outros estudos, a maior demanda por atendimento no ambulatório de nutrição foi do sexo feminino e, embora o tempo de interven- ção no serviço de nutrição tenha sido baixo, a maioria dos pacientes apresentou perda de peso, o que representa uma intervenção nutricional regular. Conclusão: A intervenção nutricional contínua se faz necessária para melhorar o estado nutricional e promover qualidade de vida para os pacientes obesos (AU)
Introduction: Obesity today represents an important public health problem e expand the number of obese patients treated in outpatient clinics of nutrition. Objectives: This article aimed to evaluate the profile and body weight gain of obese patients seen in an outpatient nutrition southern Brazil, between January 2007 and June 2012. Methods: Retrospective study using secondary data obtained from the medical records of obese patients of both genders, with age greater than or equal to 18 years, who attended at least two consultations in this health service. The outcome of the study was the percentage of variation in weight between the first and the last query in the period and the assessed variables were: age, diagnosis, number of consultations, intervention time, smoking and alcohol consumption current, intestinal function, practice of physical activity and BMI in the first and last visit. For statistical analyzes, were used tests of Chisquare, Kruskal Wallis and Bonferroni (Stata® 11.1), being considered significant values of p<0.05. Results: The study sample consisted of 451 obese patients. Most patients (72.8 %) were female and only 2.8% attended the clinic for more than 24 months. About 76 % of patients experienced weight loss, and more than half the patients showed loss of up to 5 % of their initial weight. Moreover, the greater the number of queries and the time of intervention, the greater the percentage of weight loss (p<0.001). Discussion: As well as in other studies, the increased demand for care in the outpatient clinic of nutrition was female and, although the time of intervention in nutrition service has been low, the majority of patients had weight loss, which represents a nutritional intervention regular. Conclusion: Continuous nutritional intervention is needed to improve the nutritional status and promote quality of life for obese patients (AU)